| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/1999 | CA2324582A1 New compounds |
| 09/30/1999 | CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | CA2324361A1 Anti-tumour agents |
| 09/30/1999 | CA2324347A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | CA2324345A1 Human vault rna |
| 09/30/1999 | CA2324266A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | CA2323760A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | CA2323601A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | CA2322843A1 Hypoxia-inducible human genes, proteins, and uses thereof |
| 09/30/1999 | CA2320204A1 Use of cabergoline in the treatment of restless legs syndrome |
| 09/30/1999 | CA2319335A1 Anti-tumour agents |
| 09/30/1999 | CA2305294A1 (-)-phenylpropanolamine as a sympathomimetic drug |
| 09/30/1999 | CA2290630A1 Nf-kb inhibitors containing as the active ingredient phenylmethyl benzoquinone |
| 09/30/1999 | CA2267047A1 Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity |
| 09/30/1999 | CA2264951A1 Amino acid derivatives |
| 09/30/1999 | CA2233725A1 Hemoglobin-hydroxyethyl starch complexes |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945447A1 Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections |
| 09/29/1999 | EP0945443A1 HIV inhibiting pyrimidine derivatives |
| 09/29/1999 | EP0945436A1 Cytotrienins, process for preparing the same, and antitumor agent |
| 09/29/1999 | EP0945430A2 N-phenylacetoacetamides and process for their preparation |
| 09/29/1999 | EP0945426A1 Nitrone derivatives |
| 09/29/1999 | EP0945135A2 Treatment of alzheimer's disease and modulation of immune system with Delta5-Androstenes |
| 09/29/1999 | EP0945134A1 New galenic formulations of meloxicam for oral administration |
| 09/29/1999 | EP0945133A1 Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator |
| 09/29/1999 | EP0945132A2 Ibuprofen composition |
| 09/29/1999 | EP0945131A1 Peroral drug suspension |
| 09/29/1999 | EP0945129A2 Cosmetic and/or pharmaceutical compositions |
| 09/29/1999 | EP0945128A2 Use of flavones, flavanones, or flavonoides for the protection of ascorbic acid and/or ascorbylbonds against oxidation |
| 09/29/1999 | EP0944828A1 Therapeutic agent with quantitative consumption marker and method of monitoring therapeutic agent consumption |
| 09/29/1999 | EP0944722A2 Pituitary-tumor-transforming-genes, and related products |
| 09/29/1999 | EP0944715A1 Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/29/1999 | EP0944675A1 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 09/29/1999 | EP0944651A2 Genes amplified in cancer cells |
| 09/29/1999 | EP0944648A1 Glp-1 derivatives |
| 09/29/1999 | EP0944647A1 Submucosa extracts |
| 09/29/1999 | EP0944639A1 Synthetic glycoamines, methods for their use that affect cell |
| 09/29/1999 | EP0944636A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 09/29/1999 | EP0944634A1 Epothilone analogs |
| 09/29/1999 | EP0944631A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944629A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/29/1999 | EP0944628A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/29/1999 | EP0944627A1 8-azabicyclo 3.2.1]octane-, 8-azabicyclo 3.2.1]oct-6-ene-, 9-azabicyclo 3.3.1]nonane-, 9-aza-3-oxabicyclo 3.3.1]nonane- and 9-aza-3-thiabicyclo 3.3.1]nonane derivatives, their preparation and their use as insecticides |
| 09/29/1999 | EP0944626A1 Tropane derivatives and method for their synthesis |
| 09/29/1999 | EP0944622A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944621A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944620A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944619A1 Novel integrin receptor antagonists |
| 09/29/1999 | EP0944618A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944614A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/29/1999 | EP0944613A1 Novel benzopyran derivatives |
| 09/29/1999 | EP0944612A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 09/29/1999 | EP0944611A1 Dimesylate salts of neuropeptide y ligands |
| 09/29/1999 | EP0944610A1 Asymmetric synthesis of benzoxazinones |
| 09/29/1999 | EP0944606A1 4,5-diaminopyrimidine derivatives and a method for the preparation thereof |
| 09/29/1999 | EP0944604A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944602A1 Apo b-secretion/mtp inhibitory amides |
| 09/29/1999 | EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944599A1 Triarylethanes useful as pde iv inhibitors |
| 09/29/1999 | EP0944598A2 Substituted benzamide derivatives and pharmaceutical compositions containing them |
| 09/29/1999 | EP0944597A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944596A1 Seco precursors of cyclopropylindolines and their use as prodrugs |
| 09/29/1999 | EP0944595A1 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 09/29/1999 | EP0944594A1 Inhibitors of the enzymatic activity of psa |
| 09/29/1999 | EP0944593A2 $i(CIS)-$g(D)?4 ANALOGS OF PROSTAGLANDINS AS OCULAR HYPOTENSIVES |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944590A2 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 09/29/1999 | EP0944587A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944586A2 Formulations and polymorphic forms of desferrioxamine and the preparation thereof |
| 09/29/1999 | EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 09/29/1999 | EP0944582A1 Ketobenzamides as calpain inhibitors |
| 09/29/1999 | EP0944580A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis |
| 09/29/1999 | EP0944571A1 Asiatic acid derivatives having modified a-ring |
| 09/29/1999 | EP0944399A2 Covalent polar lipid conjugates for targeting |
| 09/29/1999 | EP0944394A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/29/1999 | EP0944391A1 Use of equilenin as an antioxidant |
| 09/29/1999 | EP0944390A1 USE OF 17$g(b)-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 09/29/1999 | EP0944389A1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 09/29/1999 | EP0944388A2 Inhibitors of farnesyl-protein transferase |
| 09/29/1999 | EP0944387A1 Inhibitors of farnesyl-protein transferase |
| 09/29/1999 | EP0944386A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/29/1999 | EP0944385A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING $i(HELICOBACTER PYLORI) INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH |
| 09/29/1999 | EP0944384A1 Transdermal drug delivery system for the treatment of heart diseases |
| 09/29/1999 | EP0944321A1 Compositions for the systemic control of parasites of warm-blooded animals |
| 09/29/1999 | EP0944312A1 Compositions and methods for stimulating bone growth |
| 09/29/1999 | EP0944311A1 Heregulin antagonists and methods for their use |
| 09/29/1999 | EP0944310A1 Stabilized ascorbyl compositions |
| 09/29/1999 | EP0944309A1 Compositions for modulating intracellular inositol trisphosphate concentration and uses thereof |
| 09/29/1999 | EP0804146B1 Polyglycerine polyricinoleates |
| 09/29/1999 | EP0791005B1 Smooth muscle cell proliferation inhibitors |
| 09/29/1999 | EP0776199B1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 09/29/1999 | EP0755399B1 Lobaplatinum trihydrate |
| 09/29/1999 | EP0711140B1 Antifungal nail solution |
| 09/29/1999 | EP0642789B1 Remedy for glaucoma |
| 09/29/1999 | EP0630216B1 Adhesive bandage |
| 09/29/1999 | EP0593520B1 Ocular compositions containing steroids and their use in treating glaucoma |
| 09/29/1999 | EP0586663B1 Carbapenem derivatives as antibiotics and intermediates thereof |